Viracor's Medical Advisory Board (MAB) includes industry-leading physicians whose years of medical expertise and clinical insights help Viracor continually evolve the way we're able to innovate to serve unmet needs, impacting patient care and improving outcome
Michael G. Ison, MD MS
Medical Director, Transplant & Immunocompromised Host Infectious Diseases; Professor of Medicine (Infectious Disease) and Surgery (Organ Transplantation)
Dr. Michael Ison is an infectious disease specialist in Chicago, Illinois and is affiliated with Northwestern Memorial Hospital. His primary clinical and research areas focus on infections in transplant recipients, including norovirus, CMV and respiratory viral infections. He is a member of the Board of Directors of the United Network for Organ Sharing, the Organ Procurement and Transplant Network and of the Board of Directors of the American Society of Transplantation. Dr. Ison has also been a leader in the field of Transplant Infectious Diseases where he was the inaugural chair of the OPTN/UNOS Ad Hoc Disease Transmission Advisory Committee and was appointed by the Secretary of Health and Human Services to chair the Advisory Committee on Blood Availability and Safety. In addition, Dr. Ison has 14 years of experience in conducting Phase II, III and IV clinical trials, including several multi-center studies assessing novel antivirals in the prevention and management of CMV, BK, influenza, and RSV in transplant recipients. Dr. Ison received his medical degree from University of South Florida College of Medicine.
Michele Morris, MD
Director Immunocompromised Host Section, Div of Infectious Disease
Dr. Michele Morris is an infectious disease specialist in Miami, Florida and is affiliated with Jackson Memorial Hospital, University of Miami Hospital and Clinics and University of Miami Sylvester Comprehensive Cancer Center. Clinical areas of focus include infections in immunocompromised patients including solid organ and stem cell transplant recipients, hematology/oncology patients, primary immunodeficiency patients, and patients treated with immunosuppressive agents for rheumatologic, gastrointestinal, or dermatologic conditions, invasive fungal infections, tropical infectious diseases in immunocompromised patients, pre-transplant evaluation and clearance, HIV management in transplant candidates or recipients, and patients receiving cancer treatment. Dr. Morris received her medical degree from Perelman School of Medicine at the Medical College of Pennsylvania and has been in practice more than 20 years.
Betsy Herold, MD
Chief, Division of Pediatric Infectious Diseases, Department of Pediatrics
A renowned physician, scientist, and academic leader, Dr. Betsy Herold is a pediatric infectious disease specialist in New York, New York at Albert Einstein College of Medicine and The Children's Hospital at Montefiore. In addition to her clinical research focusing on the prevention of HIV and HSV and other sexually transmitted infections, Dr. Herold's interests include prevention of infectious disease complications in transplantation, including studies to optimize pre-emptive prophylaxis for CMV and EBV, vaccine responses in transplantation recipients, and other related infectious complications. Dr. Herold also serves as vice chair for research development in the Department of Pediatrics at CHAM and Einstein. She is a professor of Pediatrics, Microbiology and Immunology, and Obstetrics & Gynecology and Women’s Health, and holds the Harold and Muriel Block Chair of Pediatrics at Einstein. She received her medical degree from Perelman School of Medicine at the University of Pennsylvania.